Open AccessSerum Beta2-Microglobulin Levels in Hepatitis B e Antigen-Negative Chronic Hepatitits B Patients under Long-Term Lamivudine Monotherapy: Relationship with Virological Breakthrough
Author(s) -
Ioannis Elefsiniotis,
Nikolaos Scarmeas,
Irene Glynou,
Konstantinos Pantazis,
Helen Kada,
Christos Mavrogiannis
Publication year - 2004
Publication title -
canadian journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1916-7237
pISSN - 0835-7900
DOI - 10.1155/2004/864292
Subject(s) - lamivudine , medicine , gastroenterology , hazard ratio , hepatitis b , beta 2 microglobulin , proportional hazards model , hepatitis b virus , immunology , virus , confidence interval
To evaluate the predictive value of serum beta2-microglobulin (beta2m) levels for virological breakthrough in hepatitis B e antigen-negative chronic hepatitis B patients under long term lamivudine monotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom